Fig. 3From: Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemiaSurvival data for 127 patients with CMML stratified by ASXL1 mutational status (frameshift and nonsense mutations only)Back to article page